| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Poirier S | |
| Nichols-English G | |||
| P433 | issue | 4 | |
| P304 | page(s) | 475-485 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Journal of the American Pharmacists Association | Q15763872 |
| P1476 | title | Optimizing adherence to pharmaceutical care plans | |
| P478 | volume | 40 |
| Q37630024 | A Study of Medication Compliance in Geriatric Patients with Chronic Illnesses at a Tertiary Care Hospital |
| Q41975227 | Adherence to preventive medications in asthmatic children at a tertiary care teaching hospital in Malaysia |
| Q47401058 | Associations Among Depressive Symptoms, Wellness, Patient Involvement, Provider Cultural Competency, and Treatment Nonadherence: A Pilot Study Among Community Patients Seen at a University Medical Center |
| Q86763217 | Benefits of deprescribing on patients' adherence to medications |
| Q36064246 | Drug attitude and adherence: a qualitative insight of patients with hypertension. |
| Q33673866 | Effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus |
| Q92993413 | Effective factors in non-compliance with therapeutic orders of specialists in outpatient clinics in Iran: a qualitative study |
| Q34156462 | Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes |
| Q36822915 | Factors affecting therapeutic compliance: A review from the patient's perspective |
| Q36857207 | Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases |
| Q37201693 | Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus |
| Q34563048 | Issues of adherence to immunosuppressant therapy after solid-organ transplantation |
| Q35695803 | Low literacy impairs comprehension of prescription drug warning labels |
| Q37272759 | Olanzapine orally disintegrating tablet: a review of efficacy and compliance |
| Q61043954 | Pharmacists’ attitudes and perceived barriers to provision of adherence support in Australia |
| Q35855340 | Predictors of medication nonadherence differ among black and white patients with heart failure |
| Q39196860 | Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes. |
| Q64099413 | Psychotropic medication non-adherence among patients with severe mental disorder attending at Bahir Dar Felege Hiwote Referral hospital, north west Ethiopia, 2017 |
| Q39312159 | Single-dose pharmacokinetics of once-daily cyclobenzaprine extended release 30 mg versus cyclobenzaprine immediate release 10 mg three times daily in healthy young adults : a randomized, open-label, two-period crossover, single-centre study |
| Q34555677 | The B-SMART Appropriate Medication-Use Process: A Guide for Clinicians to Help Patients- Part 1: Barriers, Solutions, and Motivation |
| Q34027356 | The B-SMART Appropriate Medication-Use Process: A Guide for Clinicians to Help Patients-Part 2: Adherence, Relationships, and Triage |
| Q35665166 | Treatment non-adherence among patients with poorly controlled type 2 diabetes in ambulatory care settings in southwestern Nigeria |
| Q64355344 | Using the transtheoretical model’s stages of change to predict medication adherence in patients with type 2 diabetes mellitus in a primary health care setting |
Search more.